We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$13.8M
Cap. Flow
-$371K
Cap. Flow %
-0.14%
Top 10 Hldgs %
49.35%
Holding
208
New
7
Increased
11
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$930K
2
UL icon
Unilever
UL
+$381K
3
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$367K
4
DXCM icon
DexCom
DXCM
+$322K
5
FND icon
Floor & Decor
FND
+$290K

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$487K
2
VZ icon
Verizon
VZ
+$317K
3
SPLK
Splunk Inc
SPLK
+$314K
4
NVS icon
Novartis
NVS
+$292K
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$231K

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 8.06%
3 Financials 7.83%
4 Consumer Discretionary 6.21%
5 Industrials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
101
Aptiv
APTV
$12B
$538K 0.2%
3,421
– –
SAP icon
102
SAP
SAP
$187B
$532K 0.2%
3,790
– –
DHI icon
103
D.R. Horton
DHI
$41B
$527K 0.2%
5,829
– –
FBK icon
104
FB Financial Corp
FBK
$2.95B
$520K 0.2%
13,943
– –
EQIX icon
105
Equinix
EQIX
$107B
$512K 0.19%
638
-17
-3% -$12.6K
BABA icon
106
Alibaba
BABA
$269B
$494K 0.19%
2,180
-85
-4% -$18.9K
NXPI icon
107
NXP Semiconductors
NXPI
$68B
$483K 0.18%
2,349
– –
ICE icon
108
Intercontinental Exchange
ICE
$82.4B
$477K 0.18%
4,020
– –
SPLK
109
DELISTED
Splunk Inc
SPLK
$477K 0.18%
3,300
-2,470
-43% -$314K
CSX icon
110
CSX Corp
CSX
$98.6B
$475K 0.18%
14,799
– –
POOL icon
111
Pool Corp
POOL
$6.7B
$475K 0.18%
1,035
– –
FTNT icon
112
Fortinet
FTNT
$112B
$474K 0.18%
9,955
– –
HZNP
113
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$472K 0.18%
5,044
– –
SWKS icon
114
Skyworks Solutions
SWKS
$9.06B
$465K 0.18%
2,424
– –
CPRT icon
115
Copart
CPRT
$25.9B
$464K 0.18%
14,080
– –
ALXN
116
DELISTED
Alexion Pharmaceuticals
ALXN
$459K 0.17%
2,501
– –
ETSY icon
117
Etsy
ETSY
$7.65B
$457K 0.17%
2,220
– –
HII icon
118
Huntington Ingalls Industries
HII
$11.3B
$456K 0.17%
2,166
– –
ENTG icon
119
Entegris
ENTG
$19.7B
$455K 0.17%
3,700
– –
MNST icon
120
Monster Beverage
MNST
$91.4B
$452K 0.17%
9,904
– –
PUK icon
121
Prudential
PUK
$36.5B
$452K 0.17%
12,221
– –
ECL icon
122
Ecolab
ECL
$75.6B
$451K 0.17%
2,188
– –
VMW
123
DELISTED
VMware, Inc
VMW
$450K 0.17%
2,810
– –
WST icon
124
West Pharmaceutical
WST
$23.1B
$449K 0.17%
1,251
– –
ICLR icon
125
Icon
ICLR
$12.8B
$446K 0.17%
2,159
– –
3 4
5
6 7

Similar funds

SHFA
SS&H Financial Advisors Troy, Michigan $343M AUM 28.43% 1-Year Est. Return
YCG
Yeomans Consulting Group Marietta, Georgia $341M AUM 22.92% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
LODC
Lanham O'Dell & Company Hurricane, West Virginia $347M AUM 20.92% 1-Year Est. Return
OFS
Oldfather Financial Services Kearney, Nebraska $336M AUM 15.03% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
PPH
Pure Portfolios Holdings Lake Oswego, Oregon $332M AUM 20.54% 1-Year Est. Return
TPW
Transatlantique Private Wealth New York $319M AUM 22.93% 1-Year Est. Return

Covenant Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Covenant Partners held 208 positions worth $265M, up 5.5% from $251M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Covenant Partners's Q2 2021 filing shows 7 new, 11 increased, 28 reduced and 7 closed positions. Its largest new stake was Unilever: 5,724 shares worth $377K. The largest sale was Takeda Pharmaceutical, an estimated $487K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Covenant Partners's largest Q2 2021 buy was Unilever: 5,724 shares worth $377K.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q2 2021, an estimated $930K increase.
  • Covenant Partners's biggest Q2 2021 reduction was Takeda Pharmaceutical, cutting an estimated $487K.
  • Covenant Partners fully exited BioMarin Pharmaceuticals in Q2 2021, selling an estimated $231K.
  • Covenant Partners's ten largest holdings make up 49% of its $265M portfolio in Q2 2021.
  • Covenant Partners opened 7 new positions and closed 7 in Q2 2021.
  • Covenant Partners's portfolio value rose 5.5% quarter-over-quarter to $265M.

Based on Covenant Partners's 13F filing for Q2 2021, filed 2 Aug 2021.